ClinicalTrials.Veeva

Menu

Does Mirabegron Have a Positive Impact on Sexual Function in Females With Overactive Bladder

K

Kasr El Aini Hospital

Status

Unknown

Conditions

Females With Overactive Bladder Symptoms, Urgency & Urge Incontinence

Treatments

Drug: Follow up of female sexual function

Study type

Observational

Funder types

Other

Identifiers

NCT04511273
Cairo University Hospitals

Details and patient eligibility

About

80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms

Full description

80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms

Enrollment

80 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • any female with overactive bladder symptoms, urgency and urgency incontinence

Exclusion criteria

  • neurologic abnormalities
  • Weak bladder contractility
  • Diabetics

Trial contacts and locations

0

Loading...

Central trial contact

Samer Morsy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems